Caroline M. Apovian, MD

Professor, Medicine

Caroline Apovian
617.638.8556
72 E. Concord St Robinson (B)

Biography

Dr. Apovian’s focus is on clinical research in obesity and diabetes. Her group investigates weight loss and its effects on endothelial cell function, adipose cell metabolism and inflammation, research in the bariatric surgery population and novel pharmacotherapeutic antiobesity agents. She has become an expert in the technique for subcutaneous adipose tissue aspirations, and has been performing these aspirations on research subjects at Boston University for over 5 years. Other research projects include dietary and physical activity interventions in underserved post-partum women and the investigation into the effects of increased dietary protein on lean body mass, maximal voluntary muscle strength and power in older men with mobility limitations.

Other Positions

  • Professor, Diabetes & Endocrinology, Pediatrics, Boston University School of Medicine
  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences
  • Active Staff Privileges, Endocrinology, Diabetes, Nutrition & Weight Management, Medicine, Boston Medical Center

Education

  • University of Medicine and Dentistry of New Jersey, MD
  • Barnard College, BA

Publications

  • Published on 5/1/2019

    Wee CC, Fleishman A, McCarthy AC, Hess DT, Apovian C, Jones DB. Decision Regret up to 4 Years After Gastric Bypass and Gastric Banding. Obes Surg. 2019 May; 29(5):1624-1631. PMID: 30796614.

    Read at: PubMed
  • Published on 4/2/2019

    Gopal DM, Ayalon N, Wang YC, Siwik D, Sverdlov A, Donohue C, Perez A, Downing J, Apovian C, Silva V, Panagia M, Kolachalama V, Ho JE, Liang CS, Gokce N, Colucci WS. Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients. J Am Heart Assoc. 2019 Apr 02; 8(7):e011100. PMID: 30929550.

    Read at: PubMed
  • Published on 3/22/2019

    Fujioka K, Malhotra M, Perdomo C, Apovian CM. Effect of lorcaserin in different age groups: a post hoc analysis of patients from the BLOOM, BLOSSOM and BLOOM-DM studies. Obes Sci Pract. 2019 Apr; 5(2):120-129. PMID: 31019729.

    Read at: PubMed
  • Published on 3/20/2019

    Godfrey C, Bremer A, Alba D, Apovian C, Koethe JR, Koliwad S, Lewis D, Lo J, McComsey GA, Eckard A, Srinivasa S, Trevillyan J, Palmer C, Grinspoon S. Obesity and Fat Metabolism in HIV-infected Individuals: Immunopathogenic Mechanisms and Clinical Implications. J Infect Dis. 2019 Mar 20. PMID: 30893434.

    Read at: PubMed
  • Published on 3/5/2019

    Tsai AG, Apovian C, Kaplan L. Weight Loss Interventions in Adults. JAMA. 2019 03 05; 321(9):900. PMID: 30835301.

    Read at: PubMed
  • Published on 2/1/2019

    Srivastava G, Fox CK, Kelly AS, Jastreboff AM, Browne AF, Browne NT, Pratt JSA, Bolling C, Michalsky MP, Cook S, Lenders CM, Apovian CM. Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity. Obesity (Silver Spring). 2019 Feb; 27(2):190-204. PMID: 30677262.

    Read at: PubMed
  • Published on 1/21/2019

    Pi-Sunyer X, Apovian CM, McElroy SL, Dunayevich E, Acevedo LM, Greenway FL. Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis. Int J Obes (Lond). 2019 Jan 21. PMID: 30664661.

    Read at: PubMed
  • Published on 1/15/2019

    Rizo IM, Apovian CM. Diabetic Ketoacidosis Post Bariatric Surgery. Front Endocrinol (Lausanne). 2018; 9:812. PMID: 30697192.

    Read at: PubMed
  • Published on 11/21/2018

    Apovian CM, Okemah J, O'Neil PM. Body Weight Considerations in the Management of Type 2 Diabetes. Adv Ther. 2019 Jan; 36(1):44-58. PMID: 30465123.

    Read at: PubMed
  • Published on 11/13/2018

    Greenway FL, Aronne LJ, Raben A, Astrup A, Apovian CM, Hill JO, Kaplan LM, Fujioka K, Matejkova E, Svacina S, Luzi L, Gnessi L, Navas-Carretero S, Alfredo Martinez J, Still CD, Sannino A, Saponaro C, Demitri C, Urban LE, Leider H, Chiquette E, Ron ES, Zohar Y, Heshmati HM. A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. Obesity (Silver Spring). 2019 Feb; 27(2):205-216. PMID: 30421844.

    Read at: PubMed

View 173 more publications: View full profile at BUMC

View all profiles